Alfredo Vivas Lopez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alfredo Vivas Lopez has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Ferrero Herrero
Unit of Colorectal Surgery, Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario 12 de Octubre, Madrid, Spain
3 shared publications - Francisco Javier García Borda
Unit of Colorectal Surgery, Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario 12 de Octubre, Madrid, Spain
3 shared publications - Juan Ocaña
Department of General and Digestive Surgery Hospital Universitario Ramón Y Cajal Madrid Spain
3 shared publications - María Labalde Martínez
Unit of Colorectal Surgery, Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario 12 de Octubre, Madrid, Spain
3 shared publications - Oscar García Villar
Unit of Colorectal Surgery, Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario 12 de Octubre, Madrid, Spain
3 shared publications - Felipe de la Cruz Vigo
Unit of Colorectal Surgery, Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario 12 de Octubre, Madrid, Spain
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Metabolic and Bariatric Surgery
- Vol. 15 (2) , 113-120
Preliminary Safety Evaluation of the Bendos Q Powered Stapling System in Laparoscopic Sleeve Gastrectomy
Mañas SL, et al. J Metab Bariatr Surg. 2026 Aug;15(2):113-120. https://doi.org/10.17476/jmbs.2026.15.2.113
- 1 January 2026
- Published by XMLink in Journal of Metabolic and Bariatric Surgery
- Vol. 15 (2) , 113-120
Open AccessPreliminary Safety Evaluation of the Bendos Q Powered Stapling System in Laparoscopic Sleeve Gastrectomy
Mañas SL, et al. J Metab Bariatr Surg. 2026 Aug;15(2):113-120. https://doi.org/10.17476/jmbs.2026.15.2.113
- Open Access
- 5 June 2024
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 39 (1) , 1-7
Low anterior resection with transanal transection and single-stapled anastomosis: technical aspects and initial results
Background: Rectal cancer (RC) is a surgical challenge due to its technical complexity. The double-stapled (DS) technique, a standard for colorectal anastomosis, has been associated with notable drawbacks, including a high incidence of anastomotic leak (AL). Low anterior resection with transanal transection and single-stapled (TTSS) anastomosis has emerged to mitigate those drawbacks. Methods: Observational study in which it described the technical aspects and results of the initial group of patients with medium-low RC undergoing elective laparoscopic total mesorectal excision (TME) and TTSS. Results: Twenty-two patients were included in the series. Favourable postoperative outcomes with a median length of stay of 5 days and an AL incidence of 9.1%. Importantly, all patients achieved complete mesorectal excision with tumour-free margins, and no mortalities were reported. Conclusion: TTSS emerges as a promising alternative for patients with middle and lower rectal tumours, offering potential benefits in terms of morbidity reduction and oncological integrity compared with other techniques.
- 5 June 2024
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 39 (1) , 1-7
Open AccessLow anterior resection with transanal transection and single-stapled anastomosis: technical aspects and initial results
Background: Rectal cancer (RC) is a surgical challenge due to its technical complexity. The double-stapled (DS) technique, a standard for colorectal anastomosis, has been associated with notable drawbacks, including a high incidence of anastomotic leak (AL). Low anterior resection with transanal transection and single-stapled (TTSS) anastomosis has emerged to mitigate those drawbacks. Methods: Observational study in which it described the technical aspects and results of the initial group of patients with medium-low RC undergoing elective laparoscopic total mesorectal excision (TME) and TTSS. Results: Twenty-two patients were included in the series. Favourable postoperative outcomes with a median length of stay of 5 days and an AL incidence of 9.1%. Importantly, all patients achieved complete mesorectal excision with tumour-free margins, and no mortalities were reported. Conclusion: TTSS emerges as a promising alternative for patients with middle and lower rectal tumours, offering potential benefits in terms of morbidity reduction and oncological integrity compared with other techniques.
- Open Access
- 13 December 2021
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 41 (04) , 411-418
Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods A cohort prospective study with 50 (14 female and 36 male) patients, with a mean age of 67 (range: 55.75 to 75.25) years, who underwent surgery for rectal cancer. In total, 20 patients underwent TaTME, and 30, LaTME. Every TaTME procedure was performed by experienced colorectal surgeons. The sample was divided into two groups (TaTME and LaTME), and the quality indicators of the surgery for rectal cancer were analyzed. Results There were no statistically significant differences regarding the patients and the main characteristics of the tumor (age, gender, American Society of Anesthesiologists [ASA] score, body mass index [BMI], tumoral stage, neoadjuvant therapy, and distance from the tumor to the external anal margin) between the two groups. The rates of: postoperative morbidity (TaTME: 35%; LaTME: 30%; p = 0.763); mortality (0%); anastomotic leak (TaTME: 10%; LaTME: 13%; p = 0.722); wound infection (TaTME: 0%; LaTME: 3.3%; p = 0.409); reoperation (TaTME: 5%; LaTME: 6.6%; p = 0.808); and readmission (TaTME: 5%; LaTME: 0%; p = 0.400), as well as the length of the hospital stay (TaTME: 13.5 days; LaTME: 11 days; p = 0.538), were similar in both groups. There were no statistically significant differences in the rates of positive circumferential resection margin (TaTME: 5%; LaTME: 3.3%; p = 0.989) and positive distal resection margin (TaTME: 0%; LaTME: 3.3%; p = 0.400), the completeness of the TME (TaTME: 100%; LaTME: 100%), and the number of lymph nodes harvested (TaTME: 15; LaTME: 15.5; p = 0.882) between two groups. Conclusion Transanal total mesorectal excision is a safe and feasible surgical procedure for middle/lower-third rectal cancer.
- 13 December 2021
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 41 (04) , 411-418
Open AccessQuality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods A cohort prospective study with 50 (14 female and 36 male) patients, with a mean age of 67 (range: 55.75 to 75.25) years, who underwent surgery for rectal cancer. In total, 20 patients underwent TaTME, and 30, LaTME. Every TaTME procedure was performed by experienced colorectal surgeons. The sample was divided into two groups (TaTME and LaTME), and the quality indicators of the surgery for rectal cancer were analyzed. Results There were no statistically significant differences regarding the patients and the main characteristics of the tumor (age, gender, American Society of Anesthesiologists [ASA] score, body mass index [BMI], tumoral stage, neoadjuvant therapy, and distance from the tumor to the external anal margin) between the two groups. The rates of: postoperative morbidity (TaTME: 35%; LaTME: 30%; p = 0.763); mortality (0%); anastomotic leak (TaTME: 10%; LaTME: 13%; p = 0.722); wound infection (TaTME: 0%; LaTME: 3.3%; p = 0.409); reoperation (TaTME: 5%; LaTME: 6.6%; p = 0.808); and readmission (TaTME: 5%; LaTME: 0%; p = 0.400), as well as the length of the hospital stay (TaTME: 13.5 days; LaTME: 11 days; p = 0.538), were similar in both groups. There were no statistically significant differences in the rates of positive circumferential resection margin (TaTME: 5%; LaTME: 3.3%; p = 0.989) and positive distal resection margin (TaTME: 0%; LaTME: 3.3%; p = 0.400), the completeness of the TME (TaTME: 100%; LaTME: 100%), and the number of lymph nodes harvested (TaTME: 15; LaTME: 15.5; p = 0.882) between two groups. Conclusion Transanal total mesorectal excision is a safe and feasible surgical procedure for middle/lower-third rectal cancer.
- Open Access
- 3 June 2021
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 41 (03) , 257-264
Impact of the Covid-19 Pandemic on Colorectal Cancer Surgery in Madrid
Introduction The Covid-19 pandemic has had an important impact on colorectal cancer surgery, for hospital resources had to be redistributed in favour of Covid-19 patients. The aim of the present study is to analyze our results in colorectal oncologic surgery during the Covid-19 pandemic in patients with and without perioperative SARS-CoV-2 infection. Methods In total, 32 patients (19 male and 13 female patients), with a mean age of 64 years (range: 57.2 to 69.5 years) with colorectal cancer underwent surgery under the recommendations of surgical societies included in a protocol. Data collection included clinical characteristics (gender, age, body mass index, American Society of Anesthesiologists score, tumor location, preoperative staging, lymphopenia), data related to SARS-CoV-2 infection (postoperative symptoms, diagnostic tests), operative details (surgical procedure, approach, duration, stoma), pathological outcomes (tumor stage, number of lymph nodes harvested, distal and circumferential radial margins, quality of the total mesorectal excision), and surgical outcomes (morbidity, mortality, hospital stay, and the rates of reoperation and readmission). Results A total of 3 (9.4%) patients who underwent colorectal surgery during the Covid-19 pandemic were infected by SARS-CoV-2 in the postoperative period. Chronic obstructive pulmonary disease was associated with Covid-19 (6.2% versus 33.3%; p = 0.042), and surgical morbidity was higher among Covid-19 patients (100% versus 37.9%; p = 0.039). There were not significant differences between COVID-19 patients and non-COVID-19 patients in relation to the rest of the analyzed outcomes. Conclusion During the Covid-19 pandemic, colorectal cancer surgery should be performed according to the recommendations of surgical societies. However, Covid-19 patients could present a higher morbidity rate.
- 3 June 2021
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 41 (03) , 257-264
Open AccessImpact of the Covid-19 Pandemic on Colorectal Cancer Surgery in Madrid
Introduction The Covid-19 pandemic has had an important impact on colorectal cancer surgery, for hospital resources had to be redistributed in favour of Covid-19 patients. The aim of the present study is to analyze our results in colorectal oncologic surgery during the Covid-19 pandemic in patients with and without perioperative SARS-CoV-2 infection. Methods In total, 32 patients (19 male and 13 female patients), with a mean age of 64 years (range: 57.2 to 69.5 years) with colorectal cancer underwent surgery under the recommendations of surgical societies included in a protocol. Data collection included clinical characteristics (gender, age, body mass index, American Society of Anesthesiologists score, tumor location, preoperative staging, lymphopenia), data related to SARS-CoV-2 infection (postoperative symptoms, diagnostic tests), operative details (surgical procedure, approach, duration, stoma), pathological outcomes (tumor stage, number of lymph nodes harvested, distal and circumferential radial margins, quality of the total mesorectal excision), and surgical outcomes (morbidity, mortality, hospital stay, and the rates of reoperation and readmission). Results A total of 3 (9.4%) patients who underwent colorectal surgery during the Covid-19 pandemic were infected by SARS-CoV-2 in the postoperative period. Chronic obstructive pulmonary disease was associated with Covid-19 (6.2% versus 33.3%; p = 0.042), and surgical morbidity was higher among Covid-19 patients (100% versus 37.9%; p = 0.039). There were not significant differences between COVID-19 patients and non-COVID-19 patients in relation to the rest of the analyzed outcomes. Conclusion During the Covid-19 pandemic, colorectal cancer surgery should be performed according to the recommendations of surgical societies. However, Covid-19 patients could present a higher morbidity rate.
- 2 March 2021
- Published by Wiley in Colorectal Disease
- Vol. 23 (5) , 1291
Step‐by‐step right colectomy and intracorporeal stapled side‐to‐side ileocolic anastomosis – a video vignette
Click on the article title to read more.
- 2 March 2021
- Published by Wiley in Colorectal Disease
- Vol. 23 (5) , 1291
Step‐by‐step right colectomy and intracorporeal stapled side‐to‐side ileocolic anastomosis – a video vignette
Click on the article title to read more.
- 9 January 2021
- Published by Wiley in Colorectal Disease
- Vol. 23 (4) , 1011
Laparoscopic sigmoid resection for a giant colonic diverticulum – a video vignette
A Giant Colonic Diverticulum (GCD) is a rare manifestiation of colonic diverticular disease. It is more often located in the sigmoid colon. It is defined by a colonic diverticulum greater than 4cm in diameter (medium size 4‐9cm). It is usually located at the anti‐mesenteric border of the sigmoid colon. It was first described in 1946, although less than 200 cases are reported in the literature, mostly as case reports. While GCD pathophysiology remains unclear, the “Ball‐valve” theory is the most accepted. GCD should be managed with surgical excision. If it presents as acute diverticulitis, it should be treated according to clinical guidelines.
- 9 January 2021
- Published by Wiley in Colorectal Disease
- Vol. 23 (4) , 1011
Laparoscopic sigmoid resection for a giant colonic diverticulum – a video vignette
A Giant Colonic Diverticulum (GCD) is a rare manifestiation of colonic diverticular disease. It is more often located in the sigmoid colon. It is defined by a colonic diverticulum greater than 4cm in diameter (medium size 4‐9cm). It is usually located at the anti‐mesenteric border of the sigmoid colon. It was first described in 1946, although less than 200 cases are reported in the literature, mostly as case reports. While GCD pathophysiology remains unclear, the “Ball‐valve” theory is the most accepted. GCD should be managed with surgical excision. If it presents as acute diverticulitis, it should be treated according to clinical guidelines.